Cord blood infusion for bone marrow recovery after chemo
Treatments studied
Part of Blood & lymphatic clinical trials.
This study tests if infusing umbilical cord blood cells can safely improve blood counts after chemotherapy in adults aged 60–80 with MDS or AML who have bone marrow suppression. If you qualify, you may receive a treatment that could help your body recover its ability to make healthy blood cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 80 years old.
- You have been diagnosed with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).
- You completed chemotherapy and now have low blood counts (bone marrow suppression grade 2 or higher).
- Your liver and kidneys are working well enough (based on blood tests).
- Your heart function is normal, and you can do light activities (ECOG score 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
This study tests whether using umbilical cord blood as a stem cell transplant can improve outcomes for older adults with intermediate- or high-risk acute myeloid leukemia (AML) who are in remission. It may help reduce the risk of the cancer coming back.
This trial tests a special combination of chemotherapy drugs (thiotepa, fludarabine, ara-C, busulfan) and a growth factor (G-CSF) to prepare your body for a transplant using donated umbilical cord blood. It is for older adults (60-69) with blood cancers who cannot use a matched family donor.
This Phase 2 study tests using donated cord blood to treat certain adult blood cancers that are at high risk of coming back. It may help strengthen the body’s ability to rebuild blood and fight the cancer after intensive treatment.
This trial tests if a natural compound called sulforaphane can help your blood cells recover faster after a cord blood transplant for high-risk blood cancers. If you qualify, you would receive this supplement along with your transplant.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
Hear when a new Bone Marrow Suppression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.